The global market for Heparin Active Pharmaceutical Ingredients was valued at US$ 1837 million in the year 2024 and is projected to reach a revised size of US$ 3083 million by 2031, growing at a CAGR of 7.8% during the forecast period.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Heparin Active Pharmaceutical Ingredients competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium. In this report, we mainly study the Heparin API.
The Global key players of Heparin Active Pharmaceutical Ingredients include Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Pfizer, etc. The top three players hold a share over 39%. Asia-Pacific is the largest market, and has a share about 36%. In terms of product type, Heparin Sodium is the largest segment, which occupied for a share of about 97%. For application, LMWH is the largest segment, which has a share about 87%.
The heparin API market is primarily driven by the rising global prevalence of cardiovascular and thromboembolic diseases, along with increasing surgical procedures. Growing aging populations and higher obesity rates contribute to sustained demand for anticoagulants. Additionally, heparin's use in treating COVID-19-associated thrombotic complications has further propelled market expansion. Pharmaceutical industry advancements in emerging markets (e.g., China and India) and the biopharmaceutical sector's demand for high-quality heparin also fuel market growth.
Key trends in the heparin API market include: 1) a technological shift from animal-sourced heparin (porcine intestinal mucosa extraction) to synthetic alternatives (e.g., low-molecular-weight heparin); 2) stringent regulatory requirements for supply chain traceability and quality control; 3) intensified competition from biosimilars, driving process optimization and cost reduction; and 4) the rise of local pharmaceutical players in emerging markets, diversifying the global heparin supply chain.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Heparin Active Pharmaceutical Ingredients, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Heparin Active Pharmaceutical Ingredients.
The Heparin Active Pharmaceutical Ingredients market size, estimations, and forecasts are provided in terms of sales volume (Billion Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Heparin Active Pharmaceutical Ingredients market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Heparin Active Pharmaceutical Ingredients manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Shenzhen Hepalink Pharmaceutical
Yantai Dongcheng Pharmaceutical
Pfizer
叠颈辞颈产茅谤颈肠补
Changzhou Qianhong Biopharma
Nanjing King-friend Biochemical Pharmaceutical
Hebei Changshan Biochemical Pharmaceutical
Qingdao Jiulong Biopharmaceutical
Opocrin
Dongying Tiandong Pharmaceutical
Aspen Oss
Yino Pharma
Nanjing Xinbai Pharmaceutical
Hubei Enoray Biopharmaceutical
Cisen Pharmaceutical
Segment by Type
Heparin Sodium
Heparin Calcium
Segment by Application
UFH
LMWH
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Heparin Active Pharmaceutical Ingredients manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Heparin Active Pharmaceutical Ingredients in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Heparin Active Pharmaceutical Ingredients 麻豆原创 Overview
1.1 Product Definition
1.2 Heparin Active Pharmaceutical Ingredients by Type
1.2.1 Global Heparin Active Pharmaceutical Ingredients 麻豆原创 Value Comparison by Type (2024 VS 2031)
1.2.2 Heparin Sodium
1.2.3 Heparin Calcium
1.3 Heparin Active Pharmaceutical Ingredients by Application
1.3.1 Global Heparin Active Pharmaceutical Ingredients 麻豆原创 Value by Application (2024 VS 2031)
1.3.2 UFH
1.3.3 LMWH
1.4 Global Heparin Active Pharmaceutical Ingredients 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Heparin Active Pharmaceutical Ingredients Revenue 2020-2031
1.4.2 Global Heparin Active Pharmaceutical Ingredients Sales 2020-2031
1.4.3 Global Heparin Active Pharmaceutical Ingredients 麻豆原创 Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Heparin Active Pharmaceutical Ingredients 麻豆原创 Competition by Manufacturers
2.1 Global Heparin Active Pharmaceutical Ingredients Sales 麻豆原创 Share by Manufacturers (2020-2025)
2.2 Global Heparin Active Pharmaceutical Ingredients Revenue 麻豆原创 Share by Manufacturers (2020-2025)
2.3 Global Heparin Active Pharmaceutical Ingredients Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Heparin Active Pharmaceutical Ingredients, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Heparin Active Pharmaceutical Ingredients, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Heparin Active Pharmaceutical Ingredients, Product Type & Application
2.7 Global Key Manufacturers of Heparin Active Pharmaceutical Ingredients, Date of Enter into This Industry
2.8 Global Heparin Active Pharmaceutical Ingredients 麻豆原创 Competitive Situation and Trends
2.8.1 Global Heparin Active Pharmaceutical Ingredients 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest Heparin Active Pharmaceutical Ingredients Players 麻豆原创 Share by Revenue
2.8.3 Global Heparin Active Pharmaceutical Ingredients Company Type and 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Heparin Active Pharmaceutical Ingredients 麻豆原创 Scenario by Region
3.1 Global Heparin Active Pharmaceutical Ingredients 麻豆原创 Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Heparin Active Pharmaceutical Ingredients Sales by Region: 2020-2031
3.2.1 Global Heparin Active Pharmaceutical Ingredients Sales by Region: 2020-2025
3.2.2 Global Heparin Active Pharmaceutical Ingredients Sales by Region: 2026-2031
3.3 Global Heparin Active Pharmaceutical Ingredients Revenue by Region: 2020-2031
3.3.1 Global Heparin Active Pharmaceutical Ingredients Revenue by Region: 2020-2025
3.3.2 Global Heparin Active Pharmaceutical Ingredients Revenue by Region: 2026-2031
3.4 North America Heparin Active Pharmaceutical Ingredients 麻豆原创 Facts & Figures by Country
3.4.1 North America Heparin Active Pharmaceutical Ingredients 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Heparin Active Pharmaceutical Ingredients Sales by Country (2020-2031)
3.4.3 North America Heparin Active Pharmaceutical Ingredients Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Heparin Active Pharmaceutical Ingredients 麻豆原创 Facts & Figures by Country
3.5.1 Europe Heparin Active Pharmaceutical Ingredients 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Heparin Active Pharmaceutical Ingredients Sales by Country (2020-2031)
3.5.3 Europe Heparin Active Pharmaceutical Ingredients Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Heparin Active Pharmaceutical Ingredients 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific Heparin Active Pharmaceutical Ingredients 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Heparin Active Pharmaceutical Ingredients Sales by Region (2020-2031)
3.6.3 Asia Pacific Heparin Active Pharmaceutical Ingredients Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Heparin Active Pharmaceutical Ingredients 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Heparin Active Pharmaceutical Ingredients 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Heparin Active Pharmaceutical Ingredients Sales by Country (2020-2031)
3.7.3 Latin America Heparin Active Pharmaceutical Ingredients Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Heparin Active Pharmaceutical Ingredients 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Heparin Active Pharmaceutical Ingredients 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Heparin Active Pharmaceutical Ingredients Sales by Country (2020-2031)
3.8.3 Middle East and Africa Heparin Active Pharmaceutical Ingredients Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Heparin Active Pharmaceutical Ingredients Sales by Type (2020-2031)
4.1.1 Global Heparin Active Pharmaceutical Ingredients Sales by Type (2020-2025)
4.1.2 Global Heparin Active Pharmaceutical Ingredients Sales by Type (2026-2031)
4.1.3 Global Heparin Active Pharmaceutical Ingredients Sales 麻豆原创 Share by Type (2020-2031)
4.2 Global Heparin Active Pharmaceutical Ingredients Revenue by Type (2020-2031)
4.2.1 Global Heparin Active Pharmaceutical Ingredients Revenue by Type (2020-2025)
4.2.2 Global Heparin Active Pharmaceutical Ingredients Revenue by Type (2026-2031)
4.2.3 Global Heparin Active Pharmaceutical Ingredients Revenue 麻豆原创 Share by Type (2020-2031)
4.3 Global Heparin Active Pharmaceutical Ingredients Price by Type (2020-2031)
5 Segment by Application
5.1 Global Heparin Active Pharmaceutical Ingredients Sales by Application (2020-2031)
5.1.1 Global Heparin Active Pharmaceutical Ingredients Sales by Application (2020-2025)
5.1.2 Global Heparin Active Pharmaceutical Ingredients Sales by Application (2026-2031)
5.1.3 Global Heparin Active Pharmaceutical Ingredients Sales 麻豆原创 Share by Application (2020-2031)
5.2 Global Heparin Active Pharmaceutical Ingredients Revenue by Application (2020-2031)
5.2.1 Global Heparin Active Pharmaceutical Ingredients Revenue by Application (2020-2025)
5.2.2 Global Heparin Active Pharmaceutical Ingredients Revenue by Application (2026-2031)
5.2.3 Global Heparin Active Pharmaceutical Ingredients Revenue 麻豆原创 Share by Application (2020-2031)
5.3 Global Heparin Active Pharmaceutical Ingredients Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Shenzhen Hepalink Pharmaceutical
6.1.1 Shenzhen Hepalink Pharmaceutical Company Information
6.1.2 Shenzhen Hepalink Pharmaceutical Description and Business Overview
6.1.3 Shenzhen Hepalink Pharmaceutical Heparin Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Shenzhen Hepalink Pharmaceutical Heparin Active Pharmaceutical Ingredients Product Portfolio
6.1.5 Shenzhen Hepalink Pharmaceutical Recent Developments/Updates
6.2 Yantai Dongcheng Pharmaceutical
6.2.1 Yantai Dongcheng Pharmaceutical Company Information
6.2.2 Yantai Dongcheng Pharmaceutical Description and Business Overview
6.2.3 Yantai Dongcheng Pharmaceutical Heparin Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Yantai Dongcheng Pharmaceutical Heparin Active Pharmaceutical Ingredients Product Portfolio
6.2.5 Yantai Dongcheng Pharmaceutical Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Company Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Heparin Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Pfizer Heparin Active Pharmaceutical Ingredients Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 叠颈辞颈产茅谤颈肠补
6.4.1 叠颈辞颈产茅谤颈肠补 Company Information
6.4.2 叠颈辞颈产茅谤颈肠补 Description and Business Overview
6.4.3 叠颈辞颈产茅谤颈肠补 Heparin Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2020-2025)
6.4.4 叠颈辞颈产茅谤颈肠补 Heparin Active Pharmaceutical Ingredients Product Portfolio
6.4.5 叠颈辞颈产茅谤颈肠补 Recent Developments/Updates
6.5 Changzhou Qianhong Biopharma
6.5.1 Changzhou Qianhong Biopharma Company Information
6.5.2 Changzhou Qianhong Biopharma Description and Business Overview
6.5.3 Changzhou Qianhong Biopharma Heparin Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Changzhou Qianhong Biopharma Heparin Active Pharmaceutical Ingredients Product Portfolio
6.5.5 Changzhou Qianhong Biopharma Recent Developments/Updates
6.6 Nanjing King-friend Biochemical Pharmaceutical
6.6.1 Nanjing King-friend Biochemical Pharmaceutical Company Information
6.6.2 Nanjing King-friend Biochemical Pharmaceutical Description and Business Overview
6.6.3 Nanjing King-friend Biochemical Pharmaceutical Heparin Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Nanjing King-friend Biochemical Pharmaceutical Heparin Active Pharmaceutical Ingredients Product Portfolio
6.6.5 Nanjing King-friend Biochemical Pharmaceutical Recent Developments/Updates
6.7 Hebei Changshan Biochemical Pharmaceutical
6.7.1 Hebei Changshan Biochemical Pharmaceutical Company Information
6.7.2 Hebei Changshan Biochemical Pharmaceutical Description and Business Overview
6.7.3 Hebei Changshan Biochemical Pharmaceutical Heparin Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Hebei Changshan Biochemical Pharmaceutical Heparin Active Pharmaceutical Ingredients Product Portfolio
6.7.5 Hebei Changshan Biochemical Pharmaceutical Recent Developments/Updates
6.8 Qingdao Jiulong Biopharmaceutical
6.8.1 Qingdao Jiulong Biopharmaceutical Company Information
6.8.2 Qingdao Jiulong Biopharmaceutical Description and Business Overview
6.8.3 Qingdao Jiulong Biopharmaceutical Heparin Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Qingdao Jiulong Biopharmaceutical Heparin Active Pharmaceutical Ingredients Product Portfolio
6.8.5 Qingdao Jiulong Biopharmaceutical Recent Developments/Updates
6.9 Opocrin
6.9.1 Opocrin Company Information
6.9.2 Opocrin Description and Business Overview
6.9.3 Opocrin Heparin Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Opocrin Heparin Active Pharmaceutical Ingredients Product Portfolio
6.9.5 Opocrin Recent Developments/Updates
6.10 Dongying Tiandong Pharmaceutical
6.10.1 Dongying Tiandong Pharmaceutical Company Information
6.10.2 Dongying Tiandong Pharmaceutical Description and Business Overview
6.10.3 Dongying Tiandong Pharmaceutical Heparin Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Dongying Tiandong Pharmaceutical Heparin Active Pharmaceutical Ingredients Product Portfolio
6.10.5 Dongying Tiandong Pharmaceutical Recent Developments/Updates
6.11 Aspen Oss
6.11.1 Aspen Oss Company Information
6.11.2 Aspen Oss Description and Business Overview
6.11.3 Aspen Oss Heparin Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Aspen Oss Heparin Active Pharmaceutical Ingredients Product Portfolio
6.11.5 Aspen Oss Recent Developments/Updates
6.12 Yino Pharma
6.12.1 Yino Pharma Company Information
6.12.2 Yino Pharma Description and Business Overview
6.12.3 Yino Pharma Heparin Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Yino Pharma Heparin Active Pharmaceutical Ingredients Product Portfolio
6.12.5 Yino Pharma Recent Developments/Updates
6.13 Nanjing Xinbai Pharmaceutical
6.13.1 Nanjing Xinbai Pharmaceutical Company Information
6.13.2 Nanjing Xinbai Pharmaceutical Description and Business Overview
6.13.3 Nanjing Xinbai Pharmaceutical Heparin Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Nanjing Xinbai Pharmaceutical Heparin Active Pharmaceutical Ingredients Product Portfolio
6.13.5 Nanjing Xinbai Pharmaceutical Recent Developments/Updates
6.14 Hubei Enoray Biopharmaceutical
6.14.1 Hubei Enoray Biopharmaceutical Company Information
6.14.2 Hubei Enoray Biopharmaceutical Description and Business Overview
6.14.3 Hubei Enoray Biopharmaceutical Heparin Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Hubei Enoray Biopharmaceutical Heparin Active Pharmaceutical Ingredients Product Portfolio
6.14.5 Hubei Enoray Biopharmaceutical Recent Developments/Updates
6.15 Cisen Pharmaceutical
6.15.1 Cisen Pharmaceutical Company Information
6.15.2 Cisen Pharmaceutical Description and Business Overview
6.15.3 Cisen Pharmaceutical Heparin Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Cisen Pharmaceutical Heparin Active Pharmaceutical Ingredients Product Portfolio
6.15.5 Cisen Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Heparin Active Pharmaceutical Ingredients Industry Chain Analysis
7.2 Heparin Active Pharmaceutical Ingredients Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Heparin Active Pharmaceutical Ingredients Production Mode & Process Analysis
7.4 Heparin Active Pharmaceutical Ingredients Sales and 麻豆原创ing
7.4.1 Heparin Active Pharmaceutical Ingredients Sales Channels
7.4.2 Heparin Active Pharmaceutical Ingredients Distributors
7.5 Heparin Active Pharmaceutical Ingredients Customer Analysis
8 Heparin Active Pharmaceutical Ingredients 麻豆原创 Dynamics
8.1 Heparin Active Pharmaceutical Ingredients Industry Trends
8.2 Heparin Active Pharmaceutical Ingredients 麻豆原创 Drivers
8.3 Heparin Active Pharmaceutical Ingredients 麻豆原创 Challenges
8.4 Heparin Active Pharmaceutical Ingredients 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Shenzhen Hepalink Pharmaceutical
Yantai Dongcheng Pharmaceutical
Pfizer
叠颈辞颈产茅谤颈肠补
Changzhou Qianhong Biopharma
Nanjing King-friend Biochemical Pharmaceutical
Hebei Changshan Biochemical Pharmaceutical
Qingdao Jiulong Biopharmaceutical
Opocrin
Dongying Tiandong Pharmaceutical
Aspen Oss
Yino Pharma
Nanjing Xinbai Pharmaceutical
Hubei Enoray Biopharmaceutical
Cisen Pharmaceutical
听
听
*If Applicable.